|
|
|
|
LEADER |
01049nas a2200277 u 4500 |
001 |
10028204 |
003 |
upatras |
005 |
20210117195641.0 |
008 |
740307s1949 us q p eng |
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 21748
|a LISP
|b LISP
|c SER
|d 2016-04-24
|i 910
|l 0
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y JNL
|
999 |
|
|
|c 13098
|d 13098
|
022 |
|
|
|a 0031-6997
|
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
082 |
0 |
4 |
|a 615.1
|
110 |
|
0 |
|a American Society for Pharmacology and Experimental Therapeutics
|9 24641
|
222 |
|
0 |
|a Pharmacological reviews
|b [Περιοδικό]
|
245 |
1 |
0 |
|a Pharmacological reviews
|h [Περιοδικό]
|
260 |
|
|
|a Baltimore
|b Williams and Wilkins Co
|
310 |
|
|
|a Τριμηνιαίο
|
362 |
0 |
|
|a 33(1981) -
|
710 |
2 |
|
|a Nordisk selskab fur farmakologi.
|9 24816
|
710 |
2 |
|
|a British Pharmacological Society.
|9 24817
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b B
|k ΠΕΡ
|m 910
|t 1
|3 33(1981)-
|3 Vol.51:No.4(1999:DEC)-Vol.63:No.4(2011:DEC)
|
866 |
|
|
|a 33(1981)-
|a Vol.51:No.4(1999:DEC)-Vol.63:No.4(2011:DEC)
|
942 |
|
|
|2 ddc
|s 1
|c JNL
|